About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT02413359

High Risk Populations Among COPD Patients in Japan

The patients with complications of COPD and asthma have features mixed with two diseases, COPD and asthma. Therefore, the outcomes are worsened if the patients with COPD have symptoms overlapped with ...

Lead sponsor: AstraZeneca•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

AstraZeneca

Study Site(s), number of subjects planned Number of study sites planned for this research study (scheduled) 60 (undetermined) Number of subjects planned for this research study (scheduled) 1,100 patients

Age

40 - 150 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients with a diagnosis of COPD (FEV1/FVC\<0.7 confirmed based on the past medical records)
•Patients aged 40 years and over at the diagnosis of COPD
•Outpatient
•10 or more pack-years of current or former smokers
•Patients who have traceable medical records of COPD (including the results of spirometry) going back more than a year
•Patients who meet any of the following two criteria
•1. Patients who have medical records of the results of spirometry at more than two different time points excluding the time point of COPD exacerbations\* for the past 3 years
•2. Patients who can provide the results of reversibility testing for respiratory tract
•Patients who give written informed consent regarding the participation in this study

Exclusion Criteria

•Patients currently with COPD exacerbations
•Patients who currently enroll in the other interventional study including clinical trials
•Patients who concurrently develop or have a history of lung cancer
•Patients who are disabled to understand the study procedure or answer the questionnaire (i.e. due to the history of alcohol or drug abuse)

Related studies

Pulmonary Rehabilitation for Rural Patients With COPD

NCT06847061 · Chronic Obstructive Pulmonary Disease (COPD

Study of Patient With Frequent Exacerbations in Moscow

NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease and Asthma in Workers at Navanakorn Industrial Zone, Thailand

NCT07383896 · Asthma, COPD

Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets

NCT07112235 · COPD (Chronic Obstructive Pulmonary Disease), Rhinovirus Infection, and more

Additional Effects of Box Breathing Technique With Short Term Pulmonary Rehabilitation on Dyspnea and Functional Capacity in Patients With Chronic Obstructive Pulmonary Disease

NCT07518472 · Pulmonary Disease, Chronic Obstructive (COPD)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 21, 2016Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment1,016

Start dateMay 2015

Last updatedSep 21, 2016

Condition

Locations shown

Takenaka Respiratory Clinic

Takarazuka, Hyōgo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 21, 2016Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions